Alternative Energy Partners Launches Legal-Marijuana E-Commerce Site: Alternative Energy Partners Inc. (OTCQB: AEGY), Tranzbyte Corp. (OTCPINK: ERBB), Easton Pharmaceuticals Inc. (OTCPINK: EAPH)

Follow this company

Companies Mentioned

02/05/2014 [ACCESSWIRE]

In the quest for potential profits in the legal-marijuana market, companies are congealing daily from the cool bits of real business plans mixed with visions of wild success and super hype.

Here are three marijuana penny stocks that fit within this definition. Where they will be in the short term or long term remains to be seen, but each of them has a chance to find its niche in the future financial nirvana called the legal-marijuana industry.

Alternative Energy Partners Inc. (OTCQB: AEGY), a Florida company that legally sells medical marijuana to patients online, has become one of the most active penny stocks lately.

On Feb.4, 2014, the company's share volume soared to a volume of 260,474,167 shares, substantially higher than its daily average of 155,609,175. One reason for this sudden surge could be Alternative Energy's Jan. 31 announcement that it launched a Web site connecting collectives with patients in California.

Roll-Out First in California

The ecommerce site, with the domain name, is now open for new patient enrollment. PharmaJanes will first begin servicing parts of metropolitan Southern California, and thereafter will expand throughout California in phases. At the appropriate time, PharmaJanes intends to roll out nationwide, according to the release.  

PharmaJanes will facilitate patient enrollment in its exclusive network of dispensaries by processing and verifying patients' applications. In addition, PharmaJanes will route the orders to its exclusive non-profit collectives, which then will process and deliver the orders to patients. Upon completion of verification, patients will have access to all medical cannabis products available on the PharmaJanes menu.

Patients order Medical Marijuana from Comfort of Home

"By bringing technology to bear on the medical cannabis industry, PharmaJanes marks the beginning of a new era of simplified and streamlined access to medicine by patients from the comfort of their own homes," the chief technology officer of the site Frank Gomez said, in a written statement. "We are expecting this to be a solid growth engine for the company and to revolutionize the way medical cannabis is delivered to patients," he added.

AEGY shares closed at 0.0081 cent on Feb 4, down 0.0021 cent from its closing price of 1 cent the previous day.

Find out what could be the best investor's move when it comes to AEGY by getting the complete report here, or by cutting and pasting the following link in your Web browser: 

Still Trying to Work Things Out

Despite Tranzbyte Corp. (OTCPINK: ERBB) recently being forced to take back the good news that it had struck a deal with a medical-marijuana dispensary to use the dispensary units it sells, its stock volume is soaring.

On Feb. 4, Tranzbyte's stock volume hit 215,229,242 shares. This is nearly double its three-month average of 112,975,807 shares.

On Jan. 28, just three days after the Tempe, Ariz.-based company had told the world it had reached a verbal agreement with PARC, a licensed Arizona dispensary in Phoenix to use its dispensary machines, it  announced that a final written agreement could not be achieved.

The second about-face announcement then tried unsuccessfully to put a positive spin on the major misstep by saying that Tranzbyte expects to announce its new choice of lead dispensary locations within the week.

"While it would have made some sense to have our premiere location close to the Tranzbyte main offices, we will treat this as an opportunity to place our machines within states that possess a more open regulatory environment," Tranzbyte president, David Gwyther said, in a terse written statement.

No Firm Dates

It appears that some industry experts, who were unimpressed by the Tranzbyte's first announcement, were right to dismiss it as just more hype backed with very little substance.

That's because buried deep within the first glib PR release, Tranzbyte's President David Gwyther would not commit to a date when the first medical-medical marijuana vending machine would actually be up and running.

"We expect the arrival of our first machine within the next few weeks," Gwyther said in a written statement.  "Originally, our first automated dispensary was slated for delivery by the end of 2013.  However, enhancements and refinements of the machine's capabilities in November and December caused Tranzbyte to roll back the arrival date about a month," he added.

On Feb. 4, ERBB share price closed at 1 cent, unchanged from the share price at the close of the previous day.

Find out what could be the best investor's move when it comes to ERBB by getting the complete report here, or by cutting and pasting the following link in your Web browser: 

Moving Toward Medical-Marijuana Licensing

Easton Pharmaceuticals Inc. (OTCPINK: EAPH) is yet another company that has visions of selling medical marijuana products in both Canada and the United States. But whether its visions are based on any business reality or just wishful thinking and hype remains to be seen.

On Jan. 29, the Toronto-based company announced it had moved to the next level of medical marijuana negotiations towards a possible investment/partnership with a private unnamed Canadian Company, in a cryptic and wordy release, which was long on hype and short on specifics.

Easton Pharmaceuticals said it is moving towards signing a contract to retain and hire a senior legal expert on Medical Marijuana in Canada to file a growers/ distributorship license on behalf of Easton Pharmaceuticals.

According to Easton Pharmaceuticals, negotiations have progressed to the next level with a private Canadian company who in November of 2013, submitted a highly- respected detailed application with the Canadian government towards obtaining a distributorship license.

The company then went on to say that industry professionals and various insiders consider the application to be extremely strong and is believed will eventually receive approval in the near term. Easton management and consultants were impressed enough to request a list of items for its final stage of due diligence in an attempt to come to a fair and equitable agreement.

Management at Easton Pharmaceuticals are impressed with a plan to possibly make an agreement with various doctors and a compassion club that presently maintains 1500 patients who on average, it is estimated each person in the compassion club currently spends a total of $700 per month on marijuana for medicinal purposes. Easton has between 4 to 6 weeks maximum to close on an agreement acceptable to both parties.

On Feb 4, EAPH share price closed at 3 cents, up 1 cent from 2 cents share price at the close of the previous day.

Find out what could be the best investor's move when it comes to EAPH by getting the complete report here, or by cutting and pasting the following link in your Web browser: 

ABOUT US: issues momentum alerts on stocks that can provide gains to day traders. provides members with timely information and exclusive alerts on cheap and under-valued stocks in the United States with the potential to deliver gains of 100% - 200% or more. monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals is often in the know of several large investor awareness campaigns being deployed.

Timing is everything when trading Penny Stocks. Gain an Edge by joining the newsletter and receiving alerts from a Pro-Active team of researchers. Trading Alerts believes traders should have a chance at successfully trading penny stocks and invites traders and investors to be part of the Free VIP membership.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here:

Disclosure is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always own due diligence with any potential investment.


Leave a comment...

Your Name